2, 2 ± 1, 3 μg/ ml og 0, 7 ± 0, 4 μg/ ml.
Patients receiving VIR ACEPT BID (n=10) achieved nelfinavir Cmax of 4.0 ± 0.8 µg/ml and morning and evening trough concentrations of 2.2 ± 1.3 µg/ml and 0.7 ± 0.4 µg/ml, respectively.